Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate |
2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101144326-B1 |
titleOfInvention |
PCLβ4 gene-deficient mouse as an animal model to verify the effectiveness of Apax epilepsy treatment |
abstract |
In the PLCβ4 gene-deficient mouse of the present invention, SWD, which is characteristic of Apex epilepsy, is observed, and SWD decreases when a therapeutic agent for Apex epilepsy is administered, and thus, the PLCβ4 gene-deficient mouse is useful as an animal model for verifying the effect of Apex epilepsy treatment. Can be used. |
priorityDate |
2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |